Skip to main content

BMWFW future strategy presented at CeMM

Share

George Zarkalis, Gottfried Haber, Harald Mahrer, Sylvia Knapp and Giulio Superti-Furga

The Austrian Federal Ministry of Science, Research and Economy (BMWFW) presented the future strategy for the Austrian Life Science and Pharmaceutical Sector at CeMM

 

It was an honor for CeMM to host State Secretary Dr. Harald Mahrer with his delegation for a press conference to present a strategy document on the Austrian Life Science and Pharmaceutical Sector. 

CeMM is enthusiastic about the fact that life sciences have become a strategic focus point for the Federal Ministry of Science, Research and Economy, and appreciates the commitment to bring Austria among the Top 3 performers in Europe according to a number of parameters. The overall goal of the strategy is to position Austria among the innovation leaders, and to also show the positive economical and societal effect of life science research and the pharmaceutical sector in general. CeMM Director Prof. Giulio Superti-Furga pointed out during the press conference that the number of ERC projects granted to scientists in Austria within the last 3 years is already an impressive sign of the vitality of Austria’s life science research and a very good indicator for the further potential of our country in the future, demonstrating that Austria can compete on an international level. 

Among the priorities for the future mentioned by State Secretary Dr. Mahrer in the life sciences, there are: basic research, state-of-the-art infrastructure, personalized medicine, clinical research, big data management, translational efforts, and a better dialogue between science and society. CeMM is very proud to be able to claim that it is already doing pioneering work in most of these fields, and that everybody at CeMM is further committed to do everything possible to make sure that the life science strategy becomes a successful endeavor and creates an important impact.

Link to BMWFW Strategy Document: www.bmwfw.gv.at/Presse/Documents/Life_Science_Strategie_barrierefrei.pdf